Results 121 to 130 of about 2,667 (188)

Ravulizumab in the Management of Refractory Myasthenic Crisis: Clinical and Ventilatory Evidence of Early Recovery-A Case Report. [PDF]

Case Rep Neurol Med
Manlio Sgarzi, Paolo Paone, Paolo Gritti, Emanuela Agazzi, Giorgia Camera, Dario Alimonti.   +5 more
europepmc   +1 more source

Crovalimab Rescue Therapy in a Case With Genetic Complement Mediated Thrombotic Microangiopathy. [PDF]

Kidney Med
Aigner C, Prohászka Z, Szilágyi Á, Böhmig GA, Arbeiter K, Schmidt A, Sunder-Plassmann G.   +6 more
europepmc   +1 more source

Complement Inhibitors in Generalized Myasthenia Gravis: Comparison of Administration Schedules, Efficacy, and Safety. [PDF]

J Clin Med
Di Martino G, Rini N, Bonaventura A, Trovato M, Maccora S, Lima SM, La Seta C, Brighina F, Di Stefano V.   +8 more
europepmc   +1 more source

Iptacopan and danicopan for paroxysmal nocturnal hemoglobinuria. [PDF]

Agboola, Foluso, Carlson, Josh J, Dickerson, Ronald, Fahim, Shahariar Mohammed, Herce-Hagiwara, Belen, Makam, Anil N, Pearson, Steven D, Richardson, Marina, Suh, Kangho   +8 more
core   +1 more source

Successful Birth After First-Trimester Ravulizumab Exposure in a Patient With Paroxysmal Nocturnal Hemoglobinuria: A Case Report. [PDF]

EJHaem
Morioka T, Arai S, Arai Y, Konno S, Tokuda K, Matsuo T, Matsumoto K, Shirasaki R, Ooi J, Kihira C, Sasamori Y, Nagasaka K, Tashiro H.   +12 more
europepmc   +1 more source

Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case Series. [PDF]

Neurol Neuroimmunol Neuroinflamm
Rommer PS, Jiang W, Nolte JP, Mikami T, De Seze J, Sánchez P, Harel A, Alkabie S, Kaneko K, Bilodeau PA, Misu T, Kremer L, Bigaut K, Leypoldt F, Aktas O, Ringelstein M, Siffrin V, Zhang LJ, Cong H, Lowe M, Barreras P, Chen H, Piquet AL, Sotirchos ES, Kammeyer R, Zook J, Bennett JL, Berger T, Fujihara K, Levy M, Shi FD, Paul F.   +31 more
europepmc   +1 more source

Efficacy and Safety of Ravulizumab in IgA Nephropathy: A Phase 2 Randomized Double-Blind Placebo-Controlled Trial [PDF]

Fenoglio, Roberta
core   +2 more sources

Ravulizumab in IgA Nephropathy

Journal of the American Society of Nephrology
Gao, Youyuan, Huang, Yunjian
openaire   +3 more sources

A practical guide for rapid disease modifying therapy initiation and maintenance in aquaporin-4 positive neuromyelitis optica. [PDF]

Mult Scler Relat Disord
S G, Pm N, S Y, S B.
europepmc   +1 more source

The Annual Report of the National Renal Complement Therapeutics Centre 2021/22 [PDF]

Allen G, Forster N, Johnson S, Kavanagh D, Malina M, Maville C, Montgomery M, Naidoo L, Sheerin N, Turnbull C, Winn S, Wong E   +11 more
core   +1 more source